Introduction —
This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.
The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.
Links to related guidelines are provided separately:
●(See "Society guideline links: Heart failure in adults".)
●(See "Society guideline links: Heart failure in children".)
●(See "Society guideline links: Arrhythmias in adults".)
●(See "Society guideline links: Arrhythmias in children".)
●(See "Society guideline links: Syncope".)
●(See "Society guideline links: Myocarditis".)
●(See "Society guideline links: Management of cardiovascular diseases during pregnancy".)
International
●HRS/EHRA: Expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies (2011, reaffirmed 2018)
United States
●AHA: Scientific statement on genetic testing for inherited cardiovascular diseases (2020)
●AHA: Scientific statement on cardiomyopathy in children – Classification and diagnosis (2019)
●Heart Failure Society of America (HFSA): Practice guideline on genetic evaluation of cardiomyopathy (2018)
●ACC: The MOGE(S) classification of cardiomyopathy for clinicians (2014)
Europe
●European Society of Cardiology (ESC): Guidelines for the management of cardiomyopathies (2023)
●HRS/EHRA: Expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies (2011, reaffirmed 2018)
●ESC: Position statement on classification of the cardiomyopathies (2008)
United Kingdom
Japan
●[In Japanese] Japanese Circulation Society (JCS): Guideline on diagnosis and treatment of cardiomyopathies (2018)